Select Medical Holdings

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment provides physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Select Medical Holdings reports strong Q4 results and growth outlook

Select Medical Holdings demonstrated financial strength and growth potential in Q4 2022 across its divisions.
While challenges like labor market uncertainty persist, opportunities for revenue growth and strategic expansion are evident.
The company's focus on cost management and operational efficiency bodes well for future performance and stakeholder engagement.

Select Medical Holdings posts strong Q1 results, eyes growth

Select Medical Holdings (SEM) reported robust Q1 2023 results, showcasing growth across all divisions and a positive outlook for the year ahead.
The company's focus on cost management, strategic investments, and operational efficiency positions it well for continued success and market expansion.
While facing challenges such as revenue fluctuations and rising interest expenses, Select Medical Holdings remains proactive in addressing operational and financial hurdles.
Opportunities for growth through market expansion, technology utilization, and strategic initiatives underscore a promising trajectory for the company.

Select Medical Holdings reports strong Q2 performance and growth outlook

Select Medical Holdings (SEM) demonstrated robust financial performance in Q2 2023, driven by revenue growth and improved EBITDA across divisions.
The company's strategic refinancing and positive industry recognition position SEM well for future growth and operational excellence.
While facing challenges in maintaining exceptional growth rates, SEM has opportunities to capitalize on its strengths and market positioning for sustained success.

Select Medical Holdings (SEM) reports strong Q3 performance and expansion plans

Select Medical Holdings (SEM) demonstrated robust financial growth in Q3 2023, driven by improvements in various divisions.
The company's focus on expansion through new hospital openings and partnerships presents promising opportunities for future growth.
Overall, Select Medical Holdings (SEM) is well-positioned for continued success and value creation for its shareholders.

Select Medical Holdings reports strong Q4 results and growth opportunities

SEM's strong performance in Q4 2023 and strategic initiatives position the company for growth and value creation.
While facing challenges such as projected start-up losses and increased interest expenses, SEM is actively pursuing opportunities for financial optimization.
The company's focus on separating Concentra, expanding partnerships, and managing capital allocation underscores its commitment to enhancing shareholder value.
Investors should monitor SEM's progress in executing its 2024 outlook and addressing financial challenges to assess future performance.

Select Medical Holdings posts robust Q1 results and outlines growth plans

Select Medical Holdings (SEM) reported strong financial and operational performance in Q1 2024, driven by revenue growth, margin expansion, and strategic initiatives.
While facing challenges in working capital management and capital allocation decisions, SEM's focus on efficiency and growth presents opportunities for value creation and market expansion.
Investors should monitor SEM's progress in executing its growth plans, managing debt levels, and capitalizing on opportunities in the healthcare services sector.

Select Medical Holdings reports solid Q2 performance and expansion plans

Select Medical Holdings delivered a strong Q2 performance with revenue and EBITDA growth across key divisions.
The company's focus on expansion, quality healthcare services, and shareholder returns positions it well for future growth.
While facing challenges like earnings per share decline and regulatory changes, Select Medical has opportunities for market expansion and service enhancement.
Investors should monitor Concentra's performance details and the company's strategic execution in new hospital developments.

Select Medical Holdings reports strong Q3 performance and expansion plans

Select Medical Holdings delivered a robust performance in Q3, with strong revenue and EBITDA growth across all divisions.
The company's expansion plans and strategic projects indicate a focus on long-term growth and market presence.
While facing challenges in managing expansion and financing, Select Medical has opportunities to capitalize on sector growth and operational improvements.
Investors can be optimistic about Select Medical's financial health, demonstrated by the declared cash dividend and positive performance indicators.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

MECHANICSBURG, Pa. , Sept. 4, 2024 /PRNewswire/ -- Select Medical Corporation ("Select Medical") today announced the signing of a definitive agreement to purchase Valir Rehabilitation Hospital, a 50-bed inpatient rehabilitation facility in Oklahoma City, from Valir Health.

Select Medical to Acquire Oklahoma-based Valir Rehabilitation Hospital

Select Medical (SEM) expects its adjusted EBITDA between $845 million and $885 million for 2024, the mid-point of which implies a 7.1% rise from the 2023 reported figure of $807.4 million.

Select Medical's (SEM) Stock Down 16.9% Despite Q2 Earnings Beat

Select Medical Holdings Corporation (NYSE:SEM ) Q2 2024 Earnings Call Transcript August 2, 2024 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman & Co-Founder Martin Jackson - Senior EVP of Strategic Finance and Operations Conference Call Participants Ben Hendrix - RBC Capital Markets A.J. Rice - UBS Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's earnings conference call to discuss the second quarter 2024 results and the Company's business outlook.

Select Medical Holdings Corporation (SEM) Q2 2024 Earnings Call Transcript

Select Medical (SEM) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.61 per share a year ago.

Select Medical (SEM) Q2 Earnings and Revenues Top Estimates

MECHANICSBURG, Pa. , Aug. 1, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its second quarter ended June 30, 2024, and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2024 and Cash Dividend

MECHANICSBURG, Pa., and LOS ANGELES , July 31, 2024 /PRNewswire/ -- Select Medical and Cedars-Sinai today announced the launch of a specialized spine care program for patients with acute or chronic spine conditions.

SELECT MEDICAL AND CEDARS-SINAI LAUNCH SPECIALIZED SPINE CARE PROGRAM IN GREATER LOS ANGELES REGION

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Select Medical (SEM) Stock Undervalued Right Now?

Concentra Group Holdings Parent Inc

MECHANICSBURG, Pa. and ADDISON, Texas, July 24, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) and Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON), a wholly owned subsidiary of Select Medical, today announced the pricing of Concentra's initial public offering ("IPO") of 22,500,000 shares of Concentra's common stock at a price to the public of $23.50 per share.

Select Medical Holdings Corporation Announces Pricing of Concentra Group Holdings Parent, Inc. Initial Public Offering

NEW YORK , July 23, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Select Medical Holdings Corporation (NYSE: SEM) on behalf of the company's shareholders. The investigation seeks to determine whether Select Medical Holdings Corporation's directors breached their fiduciary duties in connection with recent corporate actions.

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Select Medical Holdings Corporation (NYSE: SEM)

Select Medical's (SEM) subsidiary, Concentra, starts roadshow for IPO of 22.5 million shares, aiming to list on the NYSE under ticker "CON" with an expected price range of $23-$26 per share.

Select Medical's (SEM) Unit Begins IPO Roadshow for 22.5M Shares

MECHANICSBURG, Pa. , July 15, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced that Concentra Group Holdings Parent, Inc. ("Concentra"), a wholly owned subsidiary of Select Medical, has launched a roadshow for the initial public offering ("IPO") of 22,500,000 shares of its common stock.

Select Medical Holdings Corporation Announces Launch of Concentra Group Holdings Parent, Inc. IPO Roadshow

MECHANICSBURG, Pa. , July 12, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced an estimate of certain financial results of its wholly-owned subsidiary, Concentra Group Holdings Parent, Inc. ("Concentra"), for the second quarter ended June 30, 2024 in advance of the announcement of Select Medical's actual results, which is expected to occur after market close on Thursday, August 1, 2024.

Select Medical Holdings Corporation Announces Estimate of Certain Financial Results of its Wholly-Owned Subsidiary Concentra Group Holdings Parent, Inc. for the Second Quarter Ended June 30, 2024

Select Medical (SEM) and UPMC unveil a 20-bed satellite facility of Helen M. Simpson Rehabilitation Hospital in West Shore, thus enhancing specialized inpatient rehabilitation care in Central Pennsylvania.

Select Medical (SEM) Expands Rehabilitation Services in Central PA

MECHANICSBURG, Pa. , July 10, 2024 /PRNewswire/ -- Joint venture partners Select Medical and UPMC announced plans to open Helen M.

SELECT MEDICAL AND UPMC TO OPEN SATELLITE INPATIENT REHABILITATION HOSPITAL ON WEST SHORE

Cars.com

Innoviva

Everything is expensive these days including stocks. Amid a raging bull market, it is tough to find affordable stocks to buy.

The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Select Medical (SEM) is a Strong Value Stock

MECHANICSBURG, Pa. , June 28, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2024 on Thursday, August 1, 2024 after the market closes.

Select Medical Holdings Corporation to Announce Second Quarter 2024 Results on Thursday, August 1, 2024

Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term

MECHANICSBURG, Pa. , June 26, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select") (NYSE: SEM) and Concentra Group Holdings Parent, Inc. ("Concentra"), today announced that Concentra Escrow Issuer Corporation ("Issuer"), a wholly-owned subsidiary of Concentra Health Services, Inc. ("CHSI"), has priced its offering of $650 million aggregate principal amount of 6.875% senior notes due 2032.

Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. Announce Pricing of Offering of $650 Million of 6.875% Senior Notes due 2032 by Concentra Escrow Issuer Corporation

MECHANICSBURG, Pa. , June 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select") (NYSE: SEM) and Concentra Group Holdings Parent, Inc. ("Concentra") today announced that Concentra Escrow Issuer Corporation ("Issuer"), a wholly-owned subsidiary of Concentra Health Services, Inc. ("CHSI"), commenced an offering of $750 million in aggregate principal amount of senior notes due 2032.

Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. Announce Commencement of Offering of $750 Million of Senior Notes by Concentra Escrow Issuer Corporation

Select Medical (SEM) will continue to gain from rising admissions within the Critical Illness Recovery Hospital and Rehabilitation Hospital segments.

Select Medical (SEM) Rises 42.4% YTD: More Growth Ahead?

Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.

Select Medical's (SEM) Shares Up 12.9% Since Q1 Earnings Beat

Is Select Medical (SEM) a Great Value Stock Right Now?

Select Medical Holdings Corporation (NYSE:SEM ) Q1 2024 Earnings Conference Call May 3, 2024 9:00 AM ET Company Participants Robert Ortenzio - Chief Executive Chairman and Co-Founder Martin Jackson - Senior EVP, Strategic Finance & Operations Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendrix - RBC Capital Markets A.J. Rice - UBS Bill Sutherland - The Benchmark Company Operator Good morning and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the First Quarter 2024 Results and the company's Business Outlook.

Select Medical Holdings Corporation (SEM) Q1 2024 Earnings Call Transcript

MECHANICSBURG, Pa. , May 2, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend.

News for Select Medical Holdings Stock (SEM)